Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia

Annals of Surgical Oncology

Volumn 25, Issue 6, 2018, Pages 1625-1632

  Kawamura, Taiichi ^a   Makuuchi, Rie ^a   Tokunaga, Masanori ^a   Tanizawa, Yutaka ^a   Bando, Etsuro ^a   Yasui, Hiroshi ^a   Aoyama, Takashi ^a   Inano, Toshimi ^a   Terashima, Masanori ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC ANTIMETABOLITE; OTERACIL; S 1 (COMBINATION); TEGAFUR;

ABDOMINAL ABSCESS; ADJUVANT THERAPY; AGED; AGING; ANASTOMOSIS LEAKAGE; ARM MUSCLE; ARTICLE; BLOOD VESSEL CATHETERIZATION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CATHETER INFECTION; CAUSE SPECIFIC SURVIVAL; CONGESTIVE HEART FAILURE; DELIRIUM; FEMALE; GRIP STRENGTH; HEART ARRHYTHMIA; HEMOPERITONEUM; HUMAN; HYPERTENSION; INTESTINE OBSTRUCTION; ISCHEMIC HEART DISEASE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE ORGAN FAILURE; MUSCLE MASS; OVERALL SURVIVAL; PANCREAS FISTULA; PNEUMONIA; SARCOPENIA; STOMACH CANCER; TREATMENT OUTCOME; URINARY TRACT INFECTION; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CAUSE OF DEATH; COMPLICATION; DRUG COMBINATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROGNOSIS; STOMACH TUMOR; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MULTIPLE ORGAN FAILURE; NEOPLASM STAGING; OXONIC ACID; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROGNOSIS; SARCOPENIA; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME;

EID: 85045104257     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-018-6452-3     Document Type: Article

References (34)

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.
2. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2015;7(3):290–98.
3. Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the concord health and ageing in men project. J Am Med Dir Assoc. 2015;16(7):607–13.
4. Yuki A, Shimokata H. Sarcopenia among Japanese elderly. Igakunoayumi. 2014;248(9):649–54.
5. Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26(5):1359–67.
6. Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal Cancer. Ann Surg Oncol. 2015;22(8):2663–68.
7. Okumura S, Kaido T, Hamaguchi Y, et al. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery. 2016;159(3):821–33.
8. Levolger S, van Vledder MG, Muslem R, et al. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. J Surg Oncol. 2015;112(2):208–13.
9. Zhuang CL, Huang DD, Pang WY, et al. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine. 2016;95(13):e3164.
10. Kudou K, Saeki H, Nakashima Y, et al. Prognostic significance of sarcopenia in patients with esophagogastric junction cancer or upper gastric cancer. Ann Surg Oncol. 2017 July;24(7):1804–1810. 10.1245/s10434-017-5811-9. Epub 2017 Feb 21.
11. Tegels JJ, van Vugt JL, Reisinger KW, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112(4):403–407.
12. Wang SL, Zhuang CL, Huang DD, et al. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncology. 2016;23(2):556–64.
13. Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):188. 10.1186/s12877-017-0569-2.
14. Fukuda Y, Yamamoto K, Hirao M, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2015; 19(3):986–93.
15. Zhou CJ, Zhang FM, Zhang FY, et al. Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res. 2017;211:137–46. 10.1016/j.jss.2016.12.014. Epub 2016 Dec 22.
16. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.
17. Frisancho AR. Triceps skin fold and upper arm muscle size norms for assessment of nutrition status. Am J Clin Nutr. 1974;27(10):1052–58.
18. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.
19. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.
20. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415–21.
21. Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005.
22. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.
23. NCI Common Terminology Criteria for Adverse Effects (CTCAE) Version 4. Available at: https://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 13 Nov 2016.
24. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.
25. Molina Garrido MJ, Guillen Ponce C, Fernandez Félix BM, et al. [Detection and evaluation of the role of sarcopenia in elderly patients with cancer treated with chemotherapy. ONCOSARCO project]. Rev Esp Geriatr Gerontol. 2016; 10.1016/j.regg.2016.02.003.
26. Tan BH, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333–38.
27. Mirkin KA, Luke FE, Gangi A, et al. Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis. J Gastrointest Oncol. 2017;8(3):589–95. 10.21037/jgo.2017.03.02.
28. McLeay SC, Morrish GA, Kirkpatrick CM, Green B. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. Clin Pharmacokinet. 2012;51(5):319–30.
29. Dalamaga M. Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications. World J Exp Med. 2013;3(3):26–33.
30. Rolland Y, Lauwers-Cances V, Cournot M, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. Am Geriatr Soc. 2003;51(8):1120–11204.
31. Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42(2):203–209.
32. Kim M, Shinkai S, Murayama H, Mori S. Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy x-ray absorptiometry for the assessment of body composition in a community-dwelling older population. Geriatr Gerontol Int. 2015;15(8):1013–22.
33. Reiss J, Iglseder B, Kreutzer M, et al. Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual x-ray absorptiometry. BMC Geriatr. 2016;16:52.
34. Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. Am Med Dir Assoc. 2013;14(1):10–17.